tetrandrine has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, H; Chen, Y; Guo, S; Li, J; Lin, X; Wang, X; Zhan, Y; Zhang, H | 1 |
| Sheng, X; Xie, B; Zhang, H; Zhang, S; Zhang, Z | 1 |
2 other study(ies) available for tetrandrine and Cancer of Cervix
| Article | Year |
|---|---|
Tetrandrine, a novel inhibitor of ether-à-go-go-1 (Eag1), targeted to cervical cancer development.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Movement; Cell Proliferation; CHO Cells; Cricetulus; Ether-A-Go-Go Potassium Channels; Female; HeLa Cells; Humans; Male; Membrane Potentials; Mice, Inbred BALB C; Mutation; Potassium Channel Blockers; Signal Transduction; Tumor Burden; Uterine Cervical Neoplasms; Wound Healing; Xenograft Model Antitumor Assays | 2019 |
Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Signal Transduction; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |